Skip to main content

Advertisement

Log in

Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917

  • Letter to the Editor
  • Published:
European Spine Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ruosi C, Colella G, Di Donato SL, Granata F, Di Salvatore MG, Fazioli F (2015) Surgical treatment of sacral chordoma: survival and prognostic factors. Eur Spine J 24(Suppl 7):912–917

    Article  PubMed  Google Scholar 

  2. Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144(6):427–437

    Article  PubMed  Google Scholar 

  3. Bentzen SM (2001) Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys 49(2):513–518

    Article  CAS  PubMed  Google Scholar 

  4. Kayani B, Sewell MD, Tan KA, Hanna SA, Williams R, Pollock R, Skinner J, Briggs TW (2015) Prognostic factors in the operative management of sacral chordomas. World Neurosurg 84(5):1354–1361

    Article  PubMed  Google Scholar 

  5. Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol 40(11):1412–1420

    Article  CAS  PubMed  Google Scholar 

  6. Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45–51

    Article  PubMed  Google Scholar 

  7. González-Sistal A, Sánchez AB, Del Rio MC, Arias JI, Herranz M, Ruibal A (2014) Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res 34(1):269–273

    PubMed  Google Scholar 

  8. Zou MX, Lv GH, Li J, She XL, Jiang Y (2016) Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8(2):516–529

    PubMed  PubMed Central  Google Scholar 

  9. von Witzleben A, Goerttler LT, Lennerz J, Weissinger S, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Möller P, Barth TF (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J. doi:10.1007/s00586-015-4242-1

    Google Scholar 

  10. Angelini A, Pala E, Calabrò T, Maraldi M, Ruggieri P (2015) Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol 112:344–351

    Article  PubMed  Google Scholar 

  11. Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219

    Article  PubMed  Google Scholar 

  12. Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Quraishi NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD (2015) Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24:1092–1101

    Article  PubMed  Google Scholar 

  13. Radaelli S, Stacchiotti S, Ruggieri P, Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L, Boriani S, Gronchi A, Picci P (2016) Sacral chordoma: long-term outcome of a large series of patients surgically treated at two reference centers. Spine (Phila Pa 1976) 41:1049–1057

    Article  Google Scholar 

  14. Zou MX, Huang W, Wang XB, Li J, Lv GH, Wang B, Deng YW (2015) Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients. Eur Spine J 24:1738–1746

    Article  PubMed  Google Scholar 

  15. Chen H, Zhang K, Wu G, Song D, Chen K, Yang H (2015) Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis. Int J Clin Exp Pathol 8:14741–14748

    PubMed  PubMed Central  Google Scholar 

  16. Zou MX, Huang W, Wang XB, Lv GH, Li J, Deng YW (2014) Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma. Int J Clin Exp Pathol 7:4877–4885

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Li.

Ethics declarations

Conflicts of interest and source of funding

The authors declare that there are no conflicts of interest in this work.

Ethical review committee statement

The study protocol was approved by the Institutional Review Board of Second Xiangya Hospital of Central South University, Hunan, China.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, MX., Lv, GH., Wang, XB. et al. Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917. Eur Spine J 26, 281–282 (2017). https://doi.org/10.1007/s00586-016-4819-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-016-4819-3

Keywords

Navigation